Exact Mass: 372.310025

A-Nor-5alpha-cholestan-2-one

A-Norcholestan-2-one, (5.alpha.)-

B-Norcholesterol

B-Norcholesterol; 3beta-Hydroxy-B-norcholest-5-ene

Finasteride

(1S,2R,7R,10S,11S,14S,15S)-N-tert-butyl-2,15-dimethyl-5-oxo-6-azatetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadec-3-ene-14-carboxamide

Finasteride is only found in individuals that have used or taken this drug. Finasteride is an androgen antagonist. It is an orally active testosterone 5-alpha-reductase inhibitor. Finasteride is one of the currently available pharmacologic treatment modalities with proven efficacy for treatment of androgenetic alopecia. The mechanism of action has not been fully determined, but finasteride has shown to decrease scalp DHT concentration to the levels found in hairy scalp, reduce serum DHT, increase hair regrowth, and slow hair loss. Androgenetic alopecia (AGA), or male pattern hair loss, affects approximately 50\\% of the male population. AGA is an androgen-related condition in genetically predisposed individuals. There is no treatment to completely reverse AGA in advanced stages, but with medical treatment (e.g. finasteride), the progression can be arrested and partly reversed in the majority of patients who have mild to moderate AGA. Finasteride is also used as a surgical alternative for treatment of benign prostatic hyperplasia (PubChem). The mechanism of action of finasteride is based on its preferential inhibition of type II 5alpha-reductase through the formation of a stable complex with the enzyme. Inhibition of type II 5alpha-reductase blocks the peripheral conversion of testosterone to DHT (resulting in significant decreases in serum and tissue DHT concentrations), minimal to moderate increase in serum testosterone concentrations, and substantial increases in prostatic testosterone concentrations. As DHT appears to be the principal androgen responsible for stimulation of prostatic growth, a decrease in DHT concentrations will result in a decrease in prostatic volume (approximately 20-30\\% after 6-24 months of continued therapy). Finasteride may increase the sensitivity of prostate specific antigen to detect prostate cancer. At present, finasteride remains the only intervention shown in long-term prospective phase III clinical trials to reduce the incidence of prostate cancer (PMID: 18044109, 17543725, 17414641, 17415094, 17394699). Finasteride is an androgen antagonist. Finasteride is one of the currently available pharmacologic treatment modalities with proven efficacy for treatment of androgenetic alopecia. Androgenetic alopecia (AGA), or male pattern hair loss, affects approximately 50\\% of the male population. AGA is an androgen-related condition in genetically predisposed individuals. There is no treatment to completely reverse AGA in advanced stages, but with medical treatment (e.g., finasteride), the progression can be arrested and partly reversed in the majority of patients who have mild to moderate AGA. Finasteride may increase the sensitivity of prostate specific antigen to detect prostate cancer. At present, finasteride remains the only intervention shown in long-term prospective phase III clinical trials to reduce the incidence of prostate cancer. (PMID: 18044109, 17543725, 17414641, 17415094, 17394699) [HMDB] G - Genito urinary system and sex hormones > G04 - Urologicals > G04C - Drugs used in benign prostatic hypertrophy > G04CB - Testosterone-5-alpha reductase inhibitors D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006727 - Hormone Antagonists > D065088 - Steroid Synthesis Inhibitors D004791 - Enzyme Inhibitors > D065088 - Steroid Synthesis Inhibitors > D058891 - 5-alpha Reductase Inhibitors C147908 - Hormone Therapy Agent > C547 - Hormone Antagonist > C242 - Anti-Androgen D000089162 - Genitourinary Agents > D064804 - Urological Agents C471 - Enzyme Inhibitor > C2319 - 5 Alpha-Reductase Inhibitor C1892 - Chemopreventive Agent D - Dermatologicals

MG(i-19:0/0:0/0:0)

(2R)-2,3-dihydroxypropyl 17-methyloctadecanoate

MG(i-19:0/0:0/0:0) belongs to the family of monoradyglycerols, which are glycerolipids lipids containing a common glycerol backbone to which at one fatty acyl group is attached. Their general formula is [R1]OCC(CO[R2])O[R3]. MG(i-19:0/0:0/0:0) is made up of one 17-methyloctadecanoyl(R1).

(3R, 6'Z)-3,4-Dihydro-8-hydroxy-3-(6-pentadecenyl)-1H-2-benzopyran-1-one

8-hydroxy-3-[(6E)-pentadec-6-en-1-yl]-3,4-dihydro-1H-2-benzopyran-1-one

(3R, 6Z)-3,4-Dihydro-8-hydroxy-3-(6-pentadecenyl)-1H-2-benzopyran-1-one is found in fats and oils. (3R, 6Z)-3,4-Dihydro-8-hydroxy-3-(6-pentadecenyl)-1H-2-benzopyran-1-one is a constituent of the fruit of Ginkgo biloba (ginkgo). Constituent of the fruit of Ginkgo biloba (ginkgo). (3R, 6Z)-3,4-Dihydro-8-hydroxy-3-(6-pentadecenyl)-1H-2-benzopyran-1-one is found in fats and oils and herbs and spices.

5-(10,13-Nonadecadienyl)-1,3-benzenediol

5-[(10E,13E)-nonadeca-10,13-dien-1-yl]benzene-1,3-diol

5-(10,13-Nonadecadienyl)-1,3-benzenediol is found in cereals and cereal products. 5-(10,13-Nonadecadienyl)-1,3-benzenediol is a constituent of wheat and rye flour. Constituent of wheat and rye flour. 5-(10,13-Nonadecadienyl)-1,3-benzenediol is found in cereals and cereal products.

Nabilone

(6aR,10aR)-1-hydroxy-6,6-dimethyl-3-(2-methyloctan-2-yl)-6H,6aH,7H,8H,9H,10H,10aH-benzo[c]isochromen-9-one

Nabilone is a synthetic cannabinoid with therapeutic use as an antiemetic and as an adjunct analgesic for neuropathic pain. It is a synthetic cannabinoid, which mimics the main ingredient of marijuana (THC) but it has more predictable side effects and causes no or minimal euphoria. Nabilone is not derived from the cannabis plant as is dronabinol. In Canada, the United States, the United Kingdom and Mexico, nabilone is marketed as Cesamet. It was approved in 1985 by the United States FDA for treatment of chemotherapy-induced nausea and vomiting that has not responded to conventional antiemetics. Though it was approved by the FDA in 1985, the drug only began marketing in the United States in 2006. It is also approved for use in treatment of anorexia and weight loss in patients with AIDS. Although it doesnt have the official indication (except in Mexico), nabilone is widely used as an adjunct therapy for chronic pain management. Numerous trials and case studies have demonstrate various benefits for condition such as fibromyalgia and multiple scerosis. Nabilone is a racemate consisting of the (S,S) and the (R,R) isomers (trans). A - Alimentary tract and metabolism > A04 - Antiemetics and antinauseants > A04A - Antiemetics and antinauseants D002492 - Central Nervous System Depressants > D014149 - Tranquilizing Agents > D014151 - Anti-Anxiety Agents D002491 - Central Nervous System Agents > D011619 - Psychotropic Drugs > D014149 - Tranquilizing Agents D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents C78272 - Agent Affecting Nervous System > C267 - Antiemetic Agent D005765 - Gastrointestinal Agents > D000932 - Antiemetics

Cervonoyl ethanolamide

2-Hydroxyethyl (7Z,10Z,13Z,16Z,19Z)-docosa-4,7,10,13,16,19-hexaenoic acid

Cervonoyl ethanolamide is a N-acylethanolamine. N-acylethanolamines (NAEs) constitute a class of lipid compounds naturally present in both animal and plant membranes as constituents of the membrane-bound phospholipid, N-acylphosphatidylethanolamine (NAPE). NAPE is composed of a third fatty acid moiety linked to the amino head group of the commonly occurring membrane phospholipid, phosphatidylethanolamine. NAEs are released from NAPE by phospholipase D-type hydrolases in response to a variety of stimuli. Transient NAE release and accumulation has been attributed a variety of biological activities, including neurotransmission, membrane protection, and immunomodulation in animals. N-oleoylethanolamine is an inhibitor of the sphingolipid signaling pathway, via specific ceramidase inhibition (ceramidase converts ceramide to sphingosine). N-oleoylethanolamine blocks the effects of TNF- and arachidonic acid on intracellular Ca concentration. (PMID: 12692337, 12056855, 12560208, 11997249) [HMDB] Cervonoyl ethanolamide is a N-acylethanolamine. N-acylethanolamines (NAEs) constitute a class of lipid compounds naturally present in both animal and plant membranes as constituents of the membrane-bound phospholipid, N-acylphosphatidylethanolamine (NAPE). NAPE is composed of a third fatty acid moiety linked to the amino head group of the commonly occurring membrane phospholipid, phosphatidylethanolamine. NAEs are released from NAPE by phospholipase D-type hydrolases in response to a variety of stimuli. Transient NAE release and accumulation has been attributed a variety of biological activities, including neurotransmission, membrane protection, and immunomodulation in animals. N-oleoylethanolamine is an inhibitor of the sphingolipid signaling pathway, via specific ceramidase inhibition (ceramidase converts ceramide to sphingosine). N-oleoylethanolamine blocks the effects of TNF- and arachidonic acid on intracellular Ca concentration. (PMID: 12692337, 12056855, 12560208, 11997249).

1-Phenyl-1,3-nonadecanedione

1-phenylnonadecane-1,3-dione

1-Phenyl-1,3-nonadecanedione is found in fats and oils. 1-Phenyl-1,3-nonadecanedione is a constituent of the pollen of Helianthus annuus (sunflower) Constituent of the pollen of Helianthus annuus (sunflower). 1-Phenyl-1,3-nonadecanedione is found in fats and oils.

MG(19:0/0:0/0:0)

(2R)-2,3-dihydroxypropyl nonadecanoate

MG(19:0/0:0/0:0) belongs to the family of monoradyglycerols, which are glycerolipids lipids containing a common glycerol backbone to which at one fatty acyl group is attached. Their general formula is [R1]OCC(CO[R2])O[R3]. MG(19:0/0:0/0:0) is made up of one nonadecanoyl(R1).

MG(0:0/19:0/0:0)

1,3-dihydroxypropan-2-yl nonadecanoate

MG(0:0/19:0/0:0) belongs to the family of monoradyglycerols, which are glycerolipids lipids containing a common glycerol backbone to which at one fatty acyl group is attached. Their general formula is [R1]OCC(CO[R2])O[R3]. MG(0:0/19:0/0:0) is made up of one nonadecanoyl(R2).

MG(0:0/i-19:0/0:0)

1,3-dihydroxypropan-2-yl 17-methyloctadecanoate

MG(0:0/i-19:0/0:0) belongs to the family of monoradyglycerols, which are glycerolipids lipids containing a common glycerol backbone to which at one fatty acyl group is attached. Their general formula is [R1]OCC(CO[R2])O[R3]. MG(0:0/i-19:0/0:0) is made up of one 17-methyloctadecanoyl(R2).

DG(8:0/10:0/0:0)

[(2S)-1-hydroxy-3-octanoyloxypropan-2-yl] decanoate

DG(8:0/10:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(8:0/10:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(8:0/0:0/10:0)

[(2R)-2-hydroxy-3-octanoyloxypropyl] decanoate

DG(8:0/0:0/10:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(10:0/8:0/0:0)

(2S)-3-hydroxy-2-(octanoyloxy)propyl decanoate

DG(10:0/8:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(10:0/8:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(10:0/0:0/8:0)

(2S)-2-hydroxy-3-(octanoyloxy)propyl decanoate

DG(10:0/0:0/8:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

Cesamet

1-hydroxy-6,6-dimethyl-3-(2-methyloctan-2-yl)-6H,6aH,7H,8H,9H,10H,10aH-benzo[c]isochromen-9-one

Anemarsaponin BIII

Senepodine E

2-[3-(furan-3-yl)propyl]-6-methyl-8-(2,6,6-trimethylcyclohex-2-en-1-yl)oct-5-en-1-ol

2,3-dihydroxypropyl 16-methyloctadecanoate

3-Oxo-chol-4-en-24-oic acid

(+)-3-Oxo-chol-4-en-24-oic acid

3beta-Hydroxy-24-methyl-chol-5-en-24-on|3beta-hydroxy-24-methyl-chol-5-en-24-one

3beta-dimethylamino-con-5-en-12beta-ol|Holarrhenine

emericolin B

(Z,Z)-3-(heptadeca-8,11-dienyl)-1,2-dimethoxybenzene|O-dimethyl-3-<8Z,11Z-heptadecadienyl>catechol

Ceralbol

(22E,24S)-24-methyl-19,27-bisnor-5alpha-cholest-22-en-3beta-ol

C28 TRIAROMATIC STERANE

C28H36 (372.2816856)

Ginkgolic acid C17:2

mycalenitrile-14

(22E)-19-nor-5alpha-cholest-22-en-3beta-ol

NSC527119

rhopaloic acid C

Me ester-19-Nor-15-prenyl-8,13,15-labdatrien-18-oic acid

Glyceryl monoricinoleate

2,3-Dihydroxypropyl 12-hydroxy-9-octadecenoate

Variculanol

SCHEMBL11732711

16R-hydroxy-20-hexa-nor-cycloartenone

Niuhinone A|niuhinone-A

2-[(9Z,12Z)-heptadeca-9,12-dienyl]-6-hydroxybenzoic acid

stellettazole D

C22H36N4O (372.2888966)

cananginone B

cananginone C

hollongdione

C22H44O4

C24H36O3

strongylodiol B

BF-2

Hydroxy-2-pentadecyl-4H-1-benzopyran-4-one

22-hydroxy-23,24,25,26,27-pentanorcucurbit-5-en-3-one|pentanorcucurbitacin A

3beta-19-Norcholest-5-en-3-ol

6-<(9Z,12Z)-heptadecadienyl>salicylic acid

C20H40N2O4 (372.29879200000005)

poecillanosine methyl ether

(22E)-3beta-(hydroxymethyl)-24-nor-A-nor-5alpha-cholest-22-ene

1-(3-Hydroxy-phenyl)-nonadec-10-en-2-on|1-(3-hydroxy-phenyl)-nonadec-10-en-2-one

3beta,21alpha-Dimethoxyserrat-14-en

Pubescimine

1-(3-Hydroxy-phenyl)-nonadec-10c-en-2-on|1-(3-hydroxy-phenyl)-nonadec-10c-en-2-one

2-O-(9-hydroxyoctadec-cis-12-enoyl)glycerol

isoleucylisoleucyllysine

Lys Leu Val

Ile Lys Ile

Lys Val Leu

Leu Val Lys

Val Lys Leu

Leu Lys Val

Lys Ile Ile

Val Leu Lys

Ginkgolic acid 17:2

2-[(8E,11E)-heptadeca-8,11-dienyl]-6-hydroxybenzoic acid

(E/Z)-Ginkgolic acid C17:2, isolated from Ginkgo biloba, can bind with human dihydroorotate dehydrogenase (DHODH) tightly[1].

Finasteride

G - Genito urinary system and sex hormones > G04 - Urologicals > G04C - Drugs used in benign prostatic hypertrophy > G04CB - Testosterone-5-alpha reductase inhibitors D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006727 - Hormone Antagonists > D065088 - Steroid Synthesis Inhibitors D004791 - Enzyme Inhibitors > D065088 - Steroid Synthesis Inhibitors > D058891 - 5-alpha Reductase Inhibitors C147908 - Hormone Therapy Agent > C547 - Hormone Antagonist > C242 - Anti-Androgen D000089162 - Genitourinary Agents > D064804 - Urological Agents C471 - Enzyme Inhibitor > C2319 - 5 Alpha-Reductase Inhibitor C1892 - Chemopreventive Agent D - Dermatologicals CONFIDENCE standard compound; INTERNAL_ID 541; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 9164; ORIGINAL_PRECURSOR_SCAN_NO 9159 CONFIDENCE standard compound; INTERNAL_ID 541; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 9203; ORIGINAL_PRECURSOR_SCAN_NO 9201 CONFIDENCE standard compound; INTERNAL_ID 541; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 9222; ORIGINAL_PRECURSOR_SCAN_NO 9221 CONFIDENCE standard compound; INTERNAL_ID 541; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 9254; ORIGINAL_PRECURSOR_SCAN_NO 9252 CONFIDENCE standard compound; INTERNAL_ID 541; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 9266; ORIGINAL_PRECURSOR_SCAN_NO 9265 CONFIDENCE standard compound; INTERNAL_ID 541; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 9274; ORIGINAL_PRECURSOR_SCAN_NO 9273 CONFIDENCE standard compound; INTERNAL_ID 2702 CONFIDENCE standard compound; INTERNAL_ID 4115

MLS001165768-01!FINASTERIDE98319-26-7

(R)-4-((8S,9S,10R,13R,14S,17R)-10,13-dimethyl-3-oxo-2,3,6,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl)pentanoic acid

"(R)-4-((8S,9S,10R,13R,14S,17R)-10,13-dimethyl-3-oxo-2,3,6,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl)pentanoic acid"

(7R,9S,10R,13R,14S,17R)-7-hydroxy-17-((R)-5-hydroxypentan-2-yl)-10,13-dimethyl-6,7,8,9,10,11,12,13,14,15,16,17-dodecahydro-3H-cyclopenta[a]phenanthren-3-one

"(7R,9S,10R,13R,14S,17R)-7-hydroxy-17-((R)-5-hydroxypentan-2-yl)-10,13-dimethyl-6,7,8,9,10,11,12,13,14,15,16,17-dodecahydro-3H-cyclopenta[a]phenanthren-3-one"

Ile Leu Lys

Leu Leu Lys

Leu Lys Leu

Lys Leu Leu

Leu Ile Lys

Leu Lys Ile

Ile Lys Leu

Lys Ile Leu

Lys Leu Ile

Ile Ile Lys

Proscar

(1S,3aS,3bS,5aR,9aR,9bS,11aS)-N-tert-butyl-9a,11a-dimethyl-7-oxo-1,2,3,3a,3b,4,5,5a,6,9b,10,11-dodecahydroindeno[5,4-f]quinoline-1-carboxamide

(5Z,7E)-(3S)-3-hydroxy-9,10-seco-5,7,10(19)-cholatrien-24-oic acid

cholacalcioic acid / 25,26,27-trinorvitamin D3 24-carboxylic acid / 25,26,27-trinorcholecalciferol 24-carboxylic acid

3-oxochol-4-en-24-oic acid

D005765 - Gastrointestinal Agents > D001647 - Bile Acids and Salts D005765 - Gastrointestinal Agents > D002793 - Cholic Acids

3-Oxo-5β-chol-1-en-24-oic Acid

(22E)-3β-Hydroxy-5α-chola-7,22-dien-24-oic Acid

3-Oxo-5β-chol-9(11)-en-24-oic Acid

3-Oxo-5β-chol-14-en-24-oic Acid

3-Oxo-5β-chol-7-en-24-oic Acid

3α-Hydroxy-5β-chola-8,14-dien-24-oic Acid

(20S,22E)-3β-Hydroxychola-5,22-dien-24-oic Acid

(22E)-3β-Hydroxychola-5,22-dien-24-oic Acid

3α-Hydroxy-5β-chola-8(14),11-dien-24-oic Acid

3α-Hydroxy-5β-chola-7,9(11)-dien-24-oic Acid

(22E)-3β-Hydroxy-5α-chola-16,22-dien-24-oic Acid

3-Oxo-5β-chol-8-en-24-oic Acid

3-Oxo-5β-chol-8(14)-en-24-oic Acid

3-Oxo-5β-chol-6-en-24-oic Acid

3-Oxo-5β,14β-chol-8-en-24-oic Acid

3β-Hydroxychola-5,7-dien-24-oic Acid

3β-Hydroxychola-5,16-dien-24-oic Acid

(20S)-3β-Hydroxychola-5,16-dien-24-oic Acid

3-OXO-CHOL-11-ENIC ACID

(+)-Dysideapalaunic acid

13,14-dihydroxy-docosanoic acid

3beta-Hydroxychola-5,16-dien-24-oic Acid

(20S)-3beta-Hydroxychola-5,16-dien-24-oic Acid

Nabilone

(−)-nabilone

A - Alimentary tract and metabolism > A04 - Antiemetics and antinauseants > A04A - Antiemetics and antinauseants D002492 - Central Nervous System Depressants > D014149 - Tranquilizing Agents > D014151 - Anti-Anxiety Agents D002491 - Central Nervous System Agents > D011619 - Psychotropic Drugs > D014149 - Tranquilizing Agents D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents C78272 - Agent Affecting Nervous System > C267 - Antiemetic Agent D005765 - Gastrointestinal Agents > D000932 - Antiemetics

1-Benzoyl-2-octadecanone

1-phenylnonadecane-1,3-dione

5-(10,13-Nonadecadienyl)resorcinol

5-[(10E,13E)-nonadeca-10,13-dien-1-yl]benzene-1,3-diol

8-hydroxy-3-[(6E)-pentadec-6-en-1-yl]-3,4-dihydro-1H-2-benzopyran-1-one

(3R, 6'Z)-3,4-Dihydro-8-hydroxy-3-(6-pentadecenyl)-1H-2-benzopyran-1-one

FA 22:0;O2

3R,7R-dihydroxy-docosanoic acid

FA 25:5

19-phenyl-15E-nonadecenoic acid

C20H40N2O4 (372.29879200000005)

alpha-N-(3-hydroxy-13-methyl-tetradecanoyl)-ornithine

5-amino-2-(3-hydroxy-13-methyl-tetradecanamido)pentanoic acid

MG O-19:1;O

1-O-(2R-hydroxy-4Z-nonadecenyl)-sn-glycerol

ST 26:1;O

24-nor-cholest-5-en-3beta-ol

ST 25:2;O2

3beta-hydroxy-26,27-bisnorcholest-5-en-24-one

Cholacalcioic acid

(5Z,7E)-(3S)-3-hydroxy-9,10-seco-5,7,10(19)-cholatrien-24-oic acid

ST 24:3;O3

(22E)-3beta-Hydroxy-5alpha-chola-16,22-dien-24-oic Acid

D005765 - Gastrointestinal Agents > D001647 - Bile Acids and Salts D005765 - Gastrointestinal Agents > D002793 - Cholic Acids

(Z)-1-(3-hydroxyphenyl)nonadec-9-en-2-one

5-((8Z,11Z)-nonadeca-8,11-dien-1-yl)resorcinol

5-((8Z,11Z)-nonadeca-8,11-dien-1-yl)benzene-1,3-diol

17b-(tert-Butylcarbamoyl)-4-aza-5a-androsten-3-one

Diethylene glycol monostearate

(E)-1,2-DIBROMO-1,2-BIS-TRIMETHYLSILANYL-ETHENE

C18H38B2O6 (372.2854348)

1-Testosterone tetrahydropyran

Glycerides, C8-10

BUTYLENE GLYCOL OLEATE

LAURAMIDOBUTYL GUANIDINE HCl

C19H40N4O3 (372.310025)

N,N-bis(2-ethylhexyl)-1H-benzotriazole-1-methylamine

C23H40N4 (372.32528)

1-hydroxy-6,6-dimethyl-3-(2-methyloctan-2-yl)-7,8,10,10a-tetrahydro-6aH-benzo[c]chromen-9-one